Literature DB >> 6754737

Cardiovascular dopamine receptors: physiological, pharmacological and therapeutic implications.

M F Lokhandwala, R J Barrett.   

Abstract

Dopamine receptor activation can lead to pronounced changes in cardiovascular function. The myriad of effects produced by dopamine receptor agonists results from the activation of dopamine receptors located at different anatomical sites in the cardiovascular system. Further basic research is required to better characterize these dopamine receptors so as to allow the development of more specific dopamine receptor agonists. Endogenous dopamine may be involved in the physiological control of fluid and electrolyte balance and continuing research efforts in this area should provide for a better understanding of the role of cardiovascular dopamine receptors in the maintenance of overall circulatory homeostasis. Cardiovascular dopamine receptor stimulation represents an important and promising approach for the development of novel therapeutic agents for the treatment of hypertension, angina pectoris, congestive heart failure and acute renal failure.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6754737     DOI: 10.1111/j.1474-8673.1982.tb00489.x

Source DB:  PubMed          Journal:  J Auton Pharmacol        ISSN: 0144-1795


  34 in total

1.  Influence of splanchnic vascular infusion on the content of endotoxins in plasma and the translocation of intestinal bacteria in rats with acute hemorrhage necrosis pancreatitis.

Authors:  Ren-Yi Qin; Sheng-Quan Zou; Zai-De Wu; Fa-Zu Qiu
Journal:  World J Gastroenterol       Date:  2000-08       Impact factor: 5.742

2.  Cardiovascular reflexes in Parkinson's disease: effect of domperidone and apomorphine.

Authors:  M Merello; Z Pirtosek; S Bishop; A J Lees
Journal:  Clin Auton Res       Date:  1992-08       Impact factor: 4.435

3.  Demonstration of dopamine DA-1 receptor sites in rat juxtaglomerular cells by light microscope autoradiography.

Authors:  F Amenta; A Ricci
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-12       Impact factor: 3.000

4.  Evidence for dopaminergic co-transmission in dog mesenteric arterial vessels.

Authors:  P Soares-da-Silva
Journal:  Br J Pharmacol       Date:  1988-09       Impact factor: 8.739

5.  Vasodilator response to dopamine in the ferret pulmonary circulation.

Authors:  P Gorman
Journal:  Br J Pharmacol       Date:  1988-05       Impact factor: 8.739

6.  Dopexamine: a novel agonist at peripheral dopamine receptors and beta 2-adrenoceptors.

Authors:  R A Brown; J Dixon; J B Farmer; J C Hall; R G Humphries; F Ince; S E O'Connor; W T Simpson; G W Smith
Journal:  Br J Pharmacol       Date:  1985-07       Impact factor: 8.739

7.  Inhibitory effects of apomorphine and pergolide on neurogenic vasoconstriction in the hindquarters of the rat.

Authors:  A G Dupont; R A Lefebvre; M G Bogaert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-04       Impact factor: 3.000

8.  Genetic mapping of two new blood pressure quantitative trait loci in the rat by genotyping endothelin system genes.

Authors:  A Y Deng; H Dene; M Pravenec; J P Rapp
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

9.  Effects of the novel dopamine DA2-receptor agonist carmoxirole (EMD 45609) on noradrenergic and purinergic neurotransmission in rat isolated kidney.

Authors:  L C Rump; K Wilde; C Bohmann; P Schollmeyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-03       Impact factor: 3.000

10.  Inhibitory dopamine receptors on sympathetic neurons innervating the cardiovascular system of the pithed rat. Characterization and role in relation to presynaptic alpha 2-adrenoceptors.

Authors:  B Wilffert; G Smit; A de Jonge; M J Thoolen; P B Timmermans; P A van Zwieten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-06       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.